$SMMT
H-2 reports significant in OS head-to-head between Ivo and Pembro in 1L PDL1 positive EGFRwt NSCLC in China
Positive read through for global trial H7 and the Ivo franchise overall.
Will keep a close eye on OS effect size among PDL1 subgroups. Recall that PFS HR largely
